ALL
Pharma?in?China
Pharma?Experts
Market News
Products Guide
Brand Story
-
EU regulators approve Takeda's Adcetris for sALCL pharmatimes
May 15, 2020European regulators have approved Takeda's Adcetris (brentuximab vedotin) for use in adults with previously untreated systemic anaplastic large cell lymphoma (sALCL) in combination with CHP (cyclophosphamide, doxorubicin, prednisone).
Pharma Sources Insight January 2025
